- Home
- MITT vs CATX Comparison
MITT vs CATX Comparison
Compare MITT & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MITT
- CATX
- Stock Information
- Founded
- MITT 2011
- CATX 1983
- Country
- MITT United States
- CATX United States
- Employees
- MITT N/A
- CATX N/A
- Industry
- MITT Real Estate Investment Trusts
- CATX Medical/Dental Instruments
- Sector
- MITT Real Estate
- CATX Health Care
- Exchange
- MITT Nasdaq
- CATX Nasdaq
- Market Cap
- MITT 204.8M
- CATX 182.9M
- IPO Year
- MITT 2011
- CATX N/A
- Fundamental
- Price
- MITT $6.96
- CATX $2.57
- Analyst Decision
- MITT Buy
- CATX Strong Buy
- Analyst Count
- MITT 5
- CATX 9
- Target Price
- MITT $8.30
- CATX $12.63
- AVG Volume (30 Days)
- MITT 162.7K
- CATX 749.8K
- Earning Date
- MITT 05-06-2025
- CATX 05-12-2025
- Dividend Yield
- MITT 11.49%
- CATX N/A
- EPS Growth
- MITT N/A
- CATX N/A
- EPS
- MITT 0.89
- CATX N/A
- Revenue
- MITT $79,955,000.00
- CATX $1,471,000.00
- Revenue This Year
- MITT N/A
- CATX N/A
- Revenue Next Year
- MITT $6.91
- CATX N/A
- P/E Ratio
- MITT $7.83
- CATX N/A
- Revenue Growth
- MITT 13.91
- CATX N/A
- 52 Week Low
- MITT $5.63
- CATX $1.60
- 52 Week High
- MITT $7.95
- CATX $16.55
- Technical
- Relative Strength Index (RSI)
- MITT 52.49
- CATX 53.32
- Support Level
- MITT $6.98
- CATX $2.34
- Resistance Level
- MITT $7.06
- CATX $2.94
- Average True Range (ATR)
- MITT 0.17
- CATX 0.28
- MACD
- MITT -0.01
- CATX 0.00
- Stochastic Oscillator
- MITT 24.19
- CATX 55.95
About MITT AG Mortgage Investment Trust Inc.
AG Mortgage Investment Trust Inc is a real estate investment trust (REIT). It focuses on investing in a diversified risk-adjusted portfolio of residential mortgage-related assets in the U.S. mortgage market. Its objective is to provide attractive risk-adjusted returns to its stockholders over the long term through dividends and capital appreciation. It also focuses on investing in residential mortgage-backed securities (RMBS) issued or guaranteed by a government-sponsored enterprise.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.